最終更新日:2024/08/03
A targeted covalent inhibitor of Bruton's tyrosine kinase and hence used in treating B cell malignancies.
正解を見る
ibrutinib
編集履歴(0)
A targeted covalent inhibitor of Bruton's tyrosine kinase and hence used in treating B cell malignancies.
ibrutinib